2020 Ophthalmology Deals, By Number of Selling Doctors
We looked at completed ophthalmology deals in 2020 to understand different practice sizes that transacted. A couple of items are of note -
We saw a fairly even distribution of small vs. medium deals, with fewer "large" deals, as expected. Most private equity firms have acquired their large platforms and are now filling-in with small and medium "add-on" transactions.
Around half of the selling groups were represented by an investment banking firm, with most of the unrepresented groups being small.
The size breakdown is shown below:
With 2020 Coming to a Promising End, 2021 is Shaping Up to be a Window of Opportunity for Ophthalmology
To learn more download our larger report on ophthalmology ... click here.
This Post is for informational purposes only and does not constitute an offer, invitation, solicitation, or recommendation to buy, sell, subscribe for, or issue any securities. While the information provided herein is believed to be accurate and reliable, 127 Capital, LLC (“Physicians First”) and Ashland Securities, LLC make no representations or warranties, expressed or implied, as to the accuracy or completeness of such information. All information contained herein is preliminary, limited and subject to completion, correction or amendment. It should not be construed as investment, legal, or tax advice and may not be reproduced or distributed to any person. Certain Principals of Physicians First are registered representatives of Ashland Securities, LLC Member FINRA, SIPC. Physicians First and Ashland Securities, LLC are separate and unaffiliated entities. Securities and Investment Banking Services are offered through Ashland Securities, LLC.